Smart Library
Faceted search across all 5 registries. Filter by registry type, evidence level, or safety domain.
New to hirudotherapy? Start here
This library indexes the full evidence base. For orientation, begin with the core guides:
Filters
Evidence level
Showing 13 of 755 entries. Refine via URL query params.
Conditions
13Cervical Radiculopathy
Tier CInvestigational use for cervical radiculopathy; no verifiable published trial specific to this indication.
Migraine
Tier CInvestigational use; the only clinical evidence is a 7-patient case series and a 26-patient non-randomized pilot, and the proposed mechanism is hypothetical.
Peyronie's Disease (Stable Phase)
Tier CInvestigational use for stable-phase Peyronie's disease; evidence limited to one uncontrolled Russian series of 29 patients. Standard treatments (verapamil, collagenase, surgery) remain first-line.
Peripheral Vertigo (BPPV-Refractory / Vestibular Neuritis Recovery)
Tier CInvestigational adjunct for peripheral vertigo persisting after Epley maneuvers or during prolonged vestibular neuritis recovery; no study specific to these conditions was identified.
Tarsal Tunnel Syndrome
Tier CInvestigational use for posterior tibial nerve entrapment at the medial ankle; no clinical study of leech therapy for it was identified.
Pubic Symphysis Dysfunction (Non-Pregnancy)
Tier CInvestigational use for non-pregnancy pubic symphysis dysfunction, including osteitis pubis; no clinical study of leech therapy was identified.
Chronic Tension-Type Headache (≥15 Days/Month)
Tier CInvestigational adjunct for chronic tension-type headache (≥15 days/month) with persistent pericranial muscle tenderness; no study in patients diagnosed with this condition was identified.
Cervicogenic Headache
Tier CInvestigational adjunct for cervicogenic headache referred from upper cervical (C1-C3) joints; no clinical study in diagnosed cases was identified.
Chronic Anal Fissure (>8 Weeks)
Tier CInvestigational idea for chronic anal fissure refractory to medical therapy; no clinical study identified; sphincterotomy remains the gold standard.
Multiple Sclerosis Fatigue (Investigational Adjunct)
Tier CInvestigational adjunct for MS-related fatigue; no clinical study was identified; disease-modifying therapy and modafinil/amantadine remain primary.
Ramsay Hunt Syndrome (Investigational Adjunct, Convalescent Phase)
Tier CInvestigational adjunct for convalescent-phase Ramsay Hunt syndrome residual facial weakness; antiviral plus corticosteroid started within 72 hours of onset remains evidence-based.
Buerger's Disease / Thromboangiitis Obliterans (Investigational Adjunct)
Tier CInvestigational adjunct for Buerger's disease; absolute tobacco cessation is the only disease-modifying intervention; iloprost and surgical sympathectomy for selected cases.
Ischial Bursitis (Investigational Adjunct)
Tier CInvestigational adjunct for refractory ischial (ischiogluteal) bursitis; activity modification, hamstring loading, and selective injection remain primary.